TornadoVM, an open-source heterogeneous programming framework for Java has reached version 7.0. It automatically accelerates ...

The country’s pharmaceutical industry has grown big enough to shift from low-cost generics to developing new drugs, said three of the country’s major pharma companies, pointing to China’s rapid shift ...

Cheap labor and global supply chains are among the obstacles to President Trump’s plan to bring generic drug manufacturing back home. Credit...Video by Harsha Vadlamani Supported by By Alex Travelli ...

Illinois residents who purchased a generic drug between May 2009 and December 2019 could be eligible for payouts as part of a series of allegations that drug companies conspired to manipulate prices.

Viatris' Mylan Pharmaceuticals asked the court, opens new tab in a filing made public on Thursday to find that its generic would not infringe Novo's patent ⁠covering a method of administering ...

Did you pay for a generic prescription drug between May 2009 and December 2019? If so, you may be eligible to receive money from settlements involving some generic drug manufacturers. The Pennsylvania ...

Sandoz Group SDZ2.55%increase; up pointing triangle said it received approval from Canada’s drug regulator for its generic version of Novo Nordisk’s NOVO.B-1.46%decrease; down pointing triangle ...

Go 1.27 has been released with new support for generic methods, along with the ability to initialize fields in nested or embedded structs directly. Go was originally developed by Google as a systems ...

On August 25, we turned our Amsterdam office café into The Blue Gopher and celebrated the Go 1.27 release with the people who built it. The event was hosted by Ainsley Clark, Go Developer Advocate at ...

If you take a patented, brand-name medication — a cancer biologic, an autoimmune drug, a specialty injection — the supply chain behind that drug is about to be permanently restructured, starting at 12 ...

Par Health has launched the first generic formulation of Janumet XR in 3 extended-release dosage strengths, offering a lower-cost alternative for glycemic control. Par Health announced the ...

U.S. President Donald Trump's plan to impose tariffs on generic drugs will lead to patients in the U.S. paying higher prices, warned the CEO of Indian pharmaceutical company Dr Reddy's. Manufacturing ...